Top stock picks for July

Catapult Group International Ltd (ASX:CAT), Vocus Communications Limited (ASX:VOC), Somnomed Limited (ASX:SOM) and Village Roadshow Ltd (ASX:VRL) are among July's recommendations.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here are some of the Foolish writers' favourite stock picks for the month of July.

Christopher Georges: Sirtex Medical Limited (ASX: SRX)

Sirtex shares have taken a hammering over the last month after the company announced it would miss its full year dose sales growth target. Although this was disappointing, it was not totally unexpected. The market appears to have over-reacted to this short-term disappointment and I believe this now presents a buying opportunity for risk tolerant investors.

Sirtex's long-term growth story remains intact and the company still has the opportunity to significantly expand its target market if ongoing clinical trials deliver positive data.

Motley Fool contributor Christopher Georges owns shares in Sirtex Medical.

James Mickleboro: Catapult Group International Ltd (ASX: CAT)

Even though the share price of Catapult Group has rocketed over 55% this year I still believe it could be a great long-term investment today. The company provides wearable technology and software to top sports clubs and athletes across the world. Its management has estimated its addressable market growing to be worth almost $5 billion per year by 2021. As one of the industry's market-leaders I feel Catapult Group is positioned for strong growth over the next few years.

Motley Fool contributor James Mickleboro has no financial interest in Catapult Group International Ltd.

Alan Edmunds: SEEK Limited (ASX: SEK)

During times of market uncertainty, I believe investors should deploy any spare funds into high-quality businesses. One such business that has suffered with the rest of the market is SEEK. Since reaffirming guidance in May, SEEK has fallen over 13% to around $15 per share. Personally I like management's intention to invest now for future growth. In my opinion such forward thinking should be welcomed by long-term investors and that is why I believe SEEK will prove to be a good investment.

Motley Fool contributor Alan Edmunds owns shares in SEEK Limited

Regan Pearson:  Story-I Ltd (ASX: SRY)

Microcap, Story-i Ltd, is tiny, growing and extremely cheap. The company is an authorised Apple product retailer throughout Indonesia, Vietnam and Myanmar. Story-i has built up 17 stores since 2010 and also targets private schooling in Indonesia, where it bundles Apple devices and e-learning programs. The company is profitable, has no significant debt and based on expected 2016 full year earnings it will have grown revenue at a compounded 10.2% over the last four years. With a current share price of $0.07, Story-i sells for a forward price-to-earnings ratio of just 3.9.

Motley Fool contributor Regan Pearson has no financial interest in Story-i Ltd.

Ryan Newman: Somnomed Limited (ASX: SOM)

Investors are right to be cautious in the wake of Britain's decision to leave the European Union, and businesses with defensive characteristics may be a good option. One such company is SomnoMed. It provides treatment solutions for sleep apnea that are less expensive and less invasive than the alternatives provided by various rivals. This makes it a more appealing option for the patient, while doctors are also more likely to recommend it based on higher compliance rates. Sleep apnea is a serious condition and one that typically needs to be treated no matter the state of the wider economy.

Motley Fool contributor Ryan Newman does not own shares of SomnoMed Limited.

Rachit Dudhwala: Clydesdale and Yorkshire Bank (ASX: CYB)

With Brexit campaigners officially winning the UK's referendum last Thursday, stocks exposed to European economies have slumped in the fallout. None more so than Clydesdale & Yorkshire Bank. Shares in the National Australia Bank spin-off have plummeted over 25% as investors assess Brexit's impact on the UK bank's future earnings. With the stock now trading well and truly below book value, long-term investors should keep an eye on European developments and look to add it to their portfolio as a rebound opportunity.

Motley Fool contributor Rachit Dudhwala does not own shares in Clydesdale & Yorkshire Bank.

Tim McArthur: Village Roadshow Ltd (ASX: VRL)

Shares in this leading entertainment and tourism company have sunk 30% since the beginning of calendar year 2016. At $5 a share, Village Roadshow is trading not only near a 52-week low, but also at its lowest level since early 2013.

Assets owned and operated by the group include theme parks such as Sea World Resort and other cinema related businesses. Providing exposure to the tourism thematic and trading on a financial year 2017 price-to-earnings ratio of 14.3 times (according to Reuters), I think the stock looks good value relative to the market.

Motley Fool contributor Tim McArthur does not own shares in Village Roadshow Ltd.

Tom Richardson: Vocus Communications Limited (ASX: VOC)

This is a re-recommendation for an internet services business that recently acquired inter-city fibre network owner NextGen to expand its physical digital-infrastructure across Australia and overseas. The stock has more than quadrupled in value over the past four years thanks to an aggressive acquisition strategy and some superb capital management in building out its tech infrastructure. Thanks to the digital tailwinds and astute management team I expect it will thump the market over the next three to five years.

Motley Fool contributor Tom Richardson owns shares in Vocus Communications.

Motley Fool contributor Motley Fool Staff has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »